Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine

Download All
Get up to date on the latest clinical data guiding optimal use of biomarkers in the care of your patients with advanced NSCLC with this educational program featuring an interactive on-demand webcast and downloadable slidesets from a live CCO webinar.
Suresh S. Ramalingam, MD, FACP, FASCO
Program Director
Stephen V. Liu, MD
Suresh S. Ramalingam, MD, FACP, FASCO
Lecia V. Sequist, MD, MPH

On-Demand Webcast

Watch this on-demand webcast of a live CCO webinar where clinical experts review the latest clinical data, including from ASCO 2021, on optimal use of predictive biomarkers to guide treatment decisions in the management of advanced NSCLC through a series of roundtable discussions.

Suresh S. Ramalingam, MD, FACP, FASCO
Program Director
Stephen V. Liu, MD Lecia V. Sequist, MD, MPH
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 26, 2021 Expired: July 25, 2022

Downloadable Slidesets

Download these slides from a live CCO Webinar for an overview of biomarker testing in advanced NSCLC along with the current status of biomarkers guiding optimal use of immunotherapy for the treatment of this disease.

Stephen V. Liu, MD Suresh S. Ramalingam, MD, FACP, FASCO Released: June 28, 2021

Download these slides from a live CCO Webinar for an overview of the latest clinical data informing optimal use of EGFR, EGFR ex20ins, and HER2 biomarkers to guide therapeutic decisions in advanced NSCLC, including updates from recent annual clinical oncology meetings.

Suresh S. Ramalingam, MD, FACP, FASCO Lecia V. Sequist, MD, MPH Released: June 28, 2021

Download these slides from a live CCO Webinar for an overview of the latest clinical data informing optimal use of ALK, ROS1, RET, NTRK, KRAS G12C, and METex14 biomarkers to guide therapeutic decisions in advanced NSCLC, including updates from recent annual clinical oncology meetings.

Stephen V. Liu, MD Lecia V. Sequist, MD, MPH Released: June 28, 2021

Download this short summary slideset of key takeaways from a live CCO Webinar on recent advances in biomarkers guiding optimal use of targeted therapy and immunotherapy in the treatment of advanced NSCLC.

Stephen V. Liu, MD Suresh S. Ramalingam, MD, FACP, FASCO Lecia V. Sequist, MD, MPH Released: July 8, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Turning Point Therapeutics Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue